Abstract

N6-methyladenosine (m6A) modification is an important mechanism in miRNA processing and maturation, but the role of its aberrant regulation in human diseases remained unclear. Here, we demonstrate that oncogenic primary microRNA-25 (miR-25) in pancreatic duct epithelial cells can be excessively maturated by cigarette smoke condensate (CSC) via enhanced m6A modification that is mediated by NF-κB associated protein (NKAP). This modification is catalyzed by overexpressed methyltransferase-like 3 (METTL3) due to hypomethylation of the METTL3 promoter also caused by CSC. Mature miR-25, miR-25-3p, suppresses PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2), resulting in the activation of oncogenic AKT-p70S6K signaling, which provokes malignant phenotypes of pancreatic cancer cells. High levels of miR-25-3p are detected in smokers and in pancreatic cancers tissues that are correlated with poor prognosis of pancreatic cancer patients. These results collectively indicate that cigarette smoke-induced miR-25-3p excessive maturation via m6A modification promotes the development and progression of pancreatic cancer.

Cigarette smoke induces microRNA dysregulation in cancers. Here, the authors show that cigarette smoke promotes the maturation of oncogenic primary miR-25 due to METTL3 hypomethylation, and mature miR-25 suppresses PH domain leucine-rich repeat protein phosphatase 2, resulting in oncogenic AKT activation in pancreatic cancer.

Details

Title
Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression
Author
Zhang, Jialiang 1 ; Bai Ruihong 1 ; Li, Mei 2 ; Ye Huilin 3 ; Wu, Chen 4   VIAFID ORCID Logo  ; Wang, Chengfeng 5 ; Li, Shengping 1 ; Tan, Liping 1 ; Mai Dongmei 1 ; Li, Guolin 3 ; Pan, Ling 1 ; Zheng Yanfen 1 ; Su Jiachun 1 ; Ye, Ying 1 ; Fu Zhiqiang 6 ; Zheng Shangyou 6 ; Zuo Zhixiang 1   VIAFID ORCID Logo  ; Liu Zexian 1   VIAFID ORCID Logo  ; Zhao, Qi 1   VIAFID ORCID Logo  ; Xu, Che 5 ; Xie, Dan 1 ; Jia Weihua 1 ; Mu-Sheng, Zeng 1   VIAFID ORCID Logo  ; Tan, Wen 4 ; Chen Rufu 3 ; Rui-Hua, Xu 1 ; Zheng, Jian 1 ; Lin Dongxin 7 

 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China (GRID:grid.488530.2) (ISNI:0000 0004 1803 6191) 
 Sun Yat-sen University Cancer Center, Department of Pathology, Guangzhou, China (GRID:grid.488530.2) (ISNI:0000 0004 1803 6191) 
 Sun Yat-sen University, Department of Pancreaticobiliary Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
 Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335); Chinese Academy of Medical Sciences and Peking Union Medical College, CAMS Key Laboratory of Genetics and Genomic Biology, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335) 
 Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Abdominal Surgery, National Cancer Center/National Clinical Research Center/Cancer Hospital, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335) 
 Sun Yat-sen University, Department of Pancreaticobiliary Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X); Sun Yat-sen University, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China (GRID:grid.488530.2) (ISNI:0000 0004 1803 6191); Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335); Chinese Academy of Medical Sciences and Peking Union Medical College, CAMS Key Laboratory of Genetics and Genomic Biology, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2393014480
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.